XML 61 R54.htm IDEA: XBRL DOCUMENT v3.25.2
CAPITAL STOCK (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 12 Months Ended
May 30, 2025
Oct. 31, 2017
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Mar. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Common stock, shares authorized     200,000,000     200,000,000
Common stock, par value     $ 0.001     $ 0.001
Warrants issued to purchase common stock 13,000,000          
Warrants exercise price $ 1          
Stock options to purchase, granted         400,000  
Options term     10 years      
Description of vesting options     The vesting of the Options was accelerated to be fully vested on May 30, 2025 upon the execution of a separation agreement with our former Chief Executive Officer.      
Remaining expenses related to options     $ 787,826 $ 1,436,038    
Stock based award, unrecognized compensation expense     0      
Stock Option [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Remaining expenses related to options     $ 48,725 $ 41,055    
Warrant [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrant issued to purchase $ 7,000,000          
Warrants outstanding     8,720,345      
Issuance of warrants, description     Each warrant provides the holder the right to purchase up to one share of our common stock at a predetermined exercise price. The outstanding warrants consist of (1) warrants to purchase 100,000 shares of common stock at an exercise price of $0.01 per share until December 2026; (2) warrants to purchase 59,034 shares of our Common Stock at an exercise price of $2.00 per share until October 2025; (3) warrants to purchase 675,000 shares of our Common Stock at an exercise price of $2.00 per share until February 2026; (4) warrants to purchase 500,000 shares of Common Stock at an exercise price of $2.00 per share until December 2025; (5) warrants to purchase 386,311 shares of Common Stock at an exercise price of $2.63 until November 2025 and (6) warrants to purchase 7,000,000 shares of common stock at an exercise price of $1.81 until May 2030.      
Warrants exercise price $ 1.81          
Warrant One [Member] | Until December 2026 [ Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     100,000      
Warrants exercise price     $ 0.01      
Warrant Two [Member] | Until October 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     59,034      
Warrants exercise price     $ 2      
Warrant Three [Member] | Until February 2026 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     675,000      
Warrants exercise price     $ 2      
Warrant Four [Member] | Until December 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     500,000      
Warrants exercise price     $ 2      
Warrant Five [Member] | Until November 2025 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     386,311      
Warrants exercise price     $ 2.63      
Warrant Six [Member] | Until May 2030 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Warrants issued to purchase common stock     7,000,000      
Warrants exercise price     $ 1.81      
2017 Equity Incentive Plan [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Shares available to be issued     1,797,164      
2017 Equity Incentive Plan [Member] | October 2020 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   4,515,000        
2017 Equity Incentive Plan [Member] | March 2023 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Increase in issuance of equity-based instruments   1,000,000        
2017 Equity Incentive Plan [Member] | February 2024 [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   9,000,000        
Increase in issuance of equity-based instruments   3,000,000        
2017 Equity Incentive Plan [Member] | Common Stock [Member]            
Accumulated Other Comprehensive Income (Loss) [Line Items]            
Number of common stock shares issued   485,000